Global/International

CLEW Launches AI-Powered Sepsis Virtual Unit to Strengthen SEP-1 Compliance

The new solution leverages real-time data and AI-driven insights to enhance early sepsis detection, optimize clinical workflows, and improve patient outcomes. ...

MoveUP Acquires Deep Structure AI to Elevate AI-Powered Orthopedic Care

The acquisition strengthens MoveUP’s AI capabilities, optimizing musculoskeletal diagnostics, predictive analytics, and personalized rehabilitation strategies for enhanced patient outcomes. ...

SkinCure Oncology Submits GentleBeam™ for FDA Clearance, Expanding Noninvasive Skin Cancer Treatment

GentleBeam™ aims to enhance Image-Guided SRT for nonmelanoma skin cancer, reinforcing SkinCure Oncology’s commitment to patient-centered, nonsurgical care. ...

Zimmer Biomet Wins FDA Nod for Metal-Safe Knee Implant

Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients...

Medtronic’s SMART Trial Confirms Evolut™ TAVR’s Superior Valve Performance at Two Years

Largest head-to-head TAVR study highlights Evolut’s lower bioprosthetic valve dysfunction and improved durability in patients with small aortic annulus, reinforcing clinical decision-making in transcatheter valve therapy....

Co-Diagnostics, Inc. Secures Dismissal of Class-Action Lawsuit

Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics....

Optellum and Volpara Health Partner to Enhance AI-Driven Cancer Risk Assessment

Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....

123Invent Introduces CTK-135 Medical Sleeve to Enhance Port Safety and Sterility

Single-use sleeve offers enhanced protection against contamination while improving efficiency for healthcare professionals....

Boston Scientific to acquire SoniVie for up to $560 million to expand renal denervation portfolio

The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy. ...

NAMSA acquires WuXi AppTec’s US medical device testing operations to expand expertise and capacity

The acquisition strengthens NAMSA’s leadership in medical device biological safety testing, adding expertise, lab capacity, and scientific resources to support global manufacturers....